A crucial element of regenerative healthcare and drug discovery lies in the ability to grow human stem cell collections to sufficient amounts for therapeutic purposes. Traditionally, limited cell supply posed a significant obstacle to advancement in these fields. Consequently, considerable endeavor has been directed towards optimizing protocols for